| 前收市價 | 323.00 |
| 開市 | 319.90 |
| 買盤 | 319.69 x 800 |
| 賣出價 | 328.03 x 4000 |
| 今日波幅 | 319.90 - 323.00 |
| 52 週波幅 | 233.12 - 325.13 |
| 成交量 | |
| 平均成交量 | 6,796 |
| 市值 | 256.082B |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 19.95 |
| 每股盈利 (最近 12 個月) | 16.05 |
| 業績公佈日 | 2024年7月25日 |
| 遠期股息及收益率 | 10.86 (3.43%) |
| 除息日 | 2024年3月14日 |
| 1 年預測目標價 | 無 |
Motley FoolWhy Weight Loss Drug Developer Stocks Tumbled on Thursday
Companies like Novo Nordisk and Eli Lilly might soon have a determined competitor in their hottest product category.
Investor's Business DailyAstraZeneca Says It Has A 'Powerful' — And Differentiated — Approach To Obesity Treatment
AstraZeneca stock skidded Thursday despite strong quarterly sales as an FDA panel met to discuss its lung cancer treatment.
ZacksRoche (RHHBY) Sales, Earnings Grow in 1H24, '24 EPS View Raised
Roche (RHHBY) records impressive second-quarter and first-half 2024 performance on the back of strong demand for drugs and tests. Consequently, the company raises its annual earnings guidance.
